EORS – Galway, Ireland – 25-28 Sept 2018
The EORS 2018 meeting will be held in Galway, Ireland. Ann Kramer is speaking on ‘The value of Diversity in growing a company’ in the Female leadership session (25th Sept 18:00-19:30) and Marco Thio is speaking on ‘Electrospinning applications in orthopaedic procedures’ (26th Sept 14:00-15:30. Meet them both at the exhibition booth. The European Orthopaedic Research… Read more »
IKC/Regener8 – Leeds, UK – 29th June
Rob McKean will attend IKC & Regener8 Annual Conference 2018 Date: June 29, 2018 @ 9:00 AM Location: Leeds The Medical Technologies IKC and Regener8 are back in 2018 to host a one-day conference on 29th June, focussing on best practice in translating regenerative devices – a potential £1bn industry in the UK. The full programme will… Read more »
Advanced Cell Culture: A Practical Approach – London – 8th June
Ann Kramer will present at the ECACC workshop Advanced Cell Culture: A Practical Approach on 8th June on the use of electrospun scaffolds in phenotypically relevant assays. Stephen Jones will be present at the exhibition stand to answer questions. A one day workshop in London, UK – Friday 8th June 2018 ECACC is excited to… Read more »
Advances in Cell and Tissue Culture – Cardiff – 22 May 2018
Stephen Jones will present a poster at Advances in Cell and Tissue Culture in Cardiff on 22 May. Dr Gary Allenby of Aurelia Biosciences will present on novel assay approaches using Mimetix microscaffolds that has been developed jointly by Aurelia and The Electrospinning Company.
UCL Innovation Forum – London – 24th April 2018
TECL’s CEO Ann Kramer will be speaking at this year’s Innovation Forum event on Regenerative Medicine. A new era in Regenerative Medicine: accelerating research from bench to bedside. You can register here. About the event Stem Cell Therapies, CAR-T, Cell and Gene Therapies, are the cutting-edge technologies of translational medicine in the 21st century. They… Read more »
Melt electrospinning arrives at The Electrospinning Company
Part of the BONE project, The Electrospinning Company will be playing a crucial role in translating academic findings using melt electrospinning into clinical-grade products. We are extremely excited to have finally received our melt electrospinning device, work together with our BONE partners towards novel medical devices and expanding our expertise in electrospinning. the Electrospinning Team
Electrospinning for drug delivery – London – 18th April 2018
The UK-China Mini-Symposium on Electrospinning for Drug Delivery will bring together researchers from both the UK and China to discuss the latest developments in this exciting and rapidly evolving field of pharmaceutical technology. It will take place in UCL’s School of Pharmacy in the heart of London. Keynote speakers: Prof Limin Zhu, Donghua University Prof… Read more »
ELRIG research and Innovation – Cambridge, UK – 17-18 April 2018
We will be at ELRIG Research and Innovation 2018 at Homerton College, Cambridge, UK on 17-18th April. Stephen Jones will present a poster on aligned fibre scaffolds for 3D cell culture.
Materials Research Exchange – London – 13th March 2018
Ann Kramer will be at The Materials Research Exchange event at the Design Centre, Islington, London on 13th March. The 2018 Materials Research Exchange Conference and Exhibition will showcase the richness of UK materials research and innovation providing an ideal opportunity to absorb current trends and take a glimpse of future innovations.
AAOS – New Orleans – March 6-10, 2018
Marco Thio will attend the American Academy of Orthopaedic Surgeons (AAOS) 2018 Annual Meeting from March 6-10th in New Orleans, USA. Please contact us if you would like to discuss the use of biomaterials / electrospun scaffolds in orthopaedic devices.
Future Healthcare – London – 13/14 March 2018
Marco Thio will be at The Future Healthcare Exhibition and Conference on 13th and 14th March.
Biomaterials Risk Management BIORIMA H2020 grant
The Electrospinning Company is a partner in the EU funded H2020 Research and Innovation action BIORIMA (Biomaterial Risk Management). The project aims to develop an integrated risk management framework for nano-biomaterials used in advanced therapeutic medicinal products and medical devices. The BIORIMA risk management framework is a structure upon which the validated tools and methods… Read more »